Sodium Hydroxide → HCID 86691762, compound
Reaction equation
[OH-].[Na+].C([O:5][C:6](=[O:38])[CH2:7][N:8]1[CH2:13][CH2:12][N:11]([S:14](=[O:37])(=[O:36])[NH:15][C:16]2[CH:21]=[C:20]([O:22][CH3:23])[N:19]=[C:18]([S:24]([CH2:27][C:28]3[CH:33]=[CH:32][CH:31]=[C:30]([F:34])[C:29]=3[F:35])(=[O:26])=[O:25])[N:17]=2)[CH2:10][CH2:9]1)C>CO>[F:35][C:29]1[C:30]([F:34])=[CH:31][CH:32]=[CH:33][C:28]=1[CH2:27][S:24]([C:18]1[N:17]=[C:16]([NH:15][S:14]([N:11]2[CH2:10][CH2:9][N:8]([CH2:7][C:6]([OH:38])=[O:5])[CH2:13][CH2:12]2)(=[O:36])=[O:37])[CH:21]=[C:20]([O:22][CH3:23])[N:19]=1)(=[O:25])=[O:26]Participants
4
Reactant 2
Product 1
Reagents, catalysts & solvents 1
Procedure
The title compound was prepared by adding 1M NaOH (1 mL) to a solution of {4-[2-(2,3-Difluoro-benzylsulfonyl)-6-methoxy-pyrimidin-4-ylsulfamoyl]-piperazin-1-yl}-acetic acid ethyl ester (the product from step i) (0.31 g) in MeOH (1 mL). Purification was by reverse phase HPLC (symmetry as the stationary phase and TFA/acetonitrile as the mobile phase) then titurated with Toluene, DCM followed by Et2O to give the title compound as a white solid. Yield: 85 mg
Workup
- customThe title compound was prepared
- customPurification
Sources & evidence
- ORD record
- ord-c14d1d1d991e4e09a86cde8b994f6048
- Source dataset
- uspto-grants-2014_05
- Patent number
- US08722883B2
Reaction notes
Loading…